Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram
出版年份 2018 全文链接
标题
Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram
作者
关键词
-
出版物
PROSTATE
Volume 79, Issue 4, Pages 352-362
出版商
Wiley
发表日期
2018-11-30
DOI
10.1002/pros.23741
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures
- (2018) Fabian Guggenberger et al. EUROPEAN UROLOGY
- Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma
- (2018) Jiayi Huang et al. JOURNAL OF NEURO-ONCOLOGY
- Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells
- (2018) Gertrud E. Feiersinger et al. Molecular Oncology
- Development of a stress response therapy targeting aggressive prostate cancer
- (2018) Hao G. Nguyen et al. Science Translational Medicine
- High speed of fork progression induces DNA replication stress and genomic instability
- (2018) Apolinar Maya-Mendoza et al. NATURE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer
- (2017) Yalcin Erzurumlu et al. Scientific Reports
- PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations
- (2016) T. Helleday ANNALS OF ONCOLOGY
- Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
- (2016) X. Lun et al. CLINICAL CANCER RESEARCH
- TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity
- (2016) Pavel Moudry et al. JOURNAL OF CELL BIOLOGY
- DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer
- (2016) Daniela Kurfurstova et al. Molecular Oncology
- Prostate cancer and the unfolded protein response
- (2016) Margrethe Storm et al. Oncotarget
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage
- (2015) Takayo Fukuda et al. CANCER SCIENCE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- Therapy escape mechanisms in the malignant prostate
- (2015) Frédéric R. Santer et al. SEMINARS IN CANCER BIOLOGY
- Blocking the formation of radiation–induced breast cancer stem cells
- (2015) Yangyang Wang et al. Oncotarget
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells
- (2014) L Kyjacova et al. CELL DEATH AND DIFFERENTIATION
- Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors for PARP Inhibitor Treatment
- (2014) K. A. T. Naipal et al. CLINICAL CANCER RESEARCH
- PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells
- (2013) Payel Chatterjee et al. PLoS One
- Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
- (2013) M T Schweizer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
- (2013) W. R. Polkinghorn et al. Cancer Discovery
- Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
- (2012) Lenka Oplustilova et al. CELL CYCLE
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
- (2011) A. W. Tolcher et al. ANNALS OF ONCOLOGY
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- Low-dose DNA damage and replication stress responses quantified by optimized automated single-cell image analysis
- (2011) Martin Mistrik et al. CELL CYCLE
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
- (2011) M. Fraser et al. CLINICAL CANCER RESEARCH
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
- (2011) Padraig Warde et al. LANCET
- Response of Human Prostate Cancer Cells and Tumors to Combining PARP Inhibition with Ionizing Radiation
- (2011) J. C. Barreto-Andrade et al. MOLECULAR CANCER THERAPEUTICS
- The role of mutant p53 in human cancer
- (2010) Amanda M Goh et al. JOURNAL OF PATHOLOGY
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- Nuclear Stress Bodies
- (2010) G. Biamonti et al. Cold Spring Harbor Perspectives in Biology
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation